Fundraising FoxMethuselah Funds
Venture capitalSpringfield · 1 people tracked
Find your way into Methuselah Funds
Sign up to see every warm intro you have to Methuselah Funds
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Methuselah Funds team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Fund manager profile
Methuselah Funds is a venture fund manager based in Springfield. SEC filings show 1 venture fund on record, most recently Methuselah Funds, LLC filed May 2018.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
Team · 1 people
from public directoriesWhat they invest in
from 7 of 8 portfolio companiesBiotech ×7Healthtech ×5Deep Tech ×4Medical Devices ×3Longevity ×2Digital Health ×1New Materials ×1
HQs:United States×6
Investments · 8 tracked
founders shown can be your intro pathBy year:2021 · 22017 · 13 dated
Leucadia Therapeutics is developing Arethusta, a first-in-class outpatient treatment for Alzheimer's disease, initially aiming to reverse mild cognitive impairment associated with the condition before targeting prevention and cure.
BiotechHealthtechLongevity
Oisín Biotechnologies develops non-viral genetic therapies built on its Fusogenix Proteo-Lipid Vehicle (PLV) delivery platform, which delivers DNA and RNA payloads to tissues throughout the body and allows repeat dosing.
BiotechHealthtechLongevitySeattle, US
Matthew Scholz(Executive Officer, Director)inEric Garcia(Executive Officer)inStephen Hilbert(Executive Officer)John Lewis(Executive Officer)inGary Hudson(Executive Officer, Director)in
BoardDavid Gobel(Director)
Co-investorsIKJ CapitalHealthspan Capital
OncoSenX is a late-stage pre-clinical cancer therapeutics company developing treatments that target solid tumors based on transcriptional activity.
BiotechDeep TechHealthtechSeattle, US
Matt Scholz(Executive Officer, Director)John Lewis(Executive Officer, Director)inGary Hudson(Director)in
Co-investorsHelios CapitalMethuselah FoundationChainFund CapitalInvesco
Viscient Biosciences develops drugs by studying human 3D tissue models combined with multi-omics analysis to understand disease mechanisms.
BiotechDeep TechDigital HealthSan Diego, US
Keith Murphy(Executive Officer, Director)in
Co-investorsHarmonix FundMethuselah FoundationThynk Capital
Volumetric Biotechnologies, acquired by 3D Systems in 2021, develops bioprinting materials and vascularized human tissue constructs.
BiotechDeep TechHealthtechMedical DevicesHouston, US
Jordan Miller(President)inBagrat Grigoryan(COO)in
Co-investorsGoAhead VenturesHarmonix FundHelios CapitalJoyance PartnersJude GomilaMethuselah Foundation+21 more
Winsantor is a clinical-stage biotechnology company developing treatments for peripheral neuropathies, including diabetic peripheral neuropathy and chemotherapy-induced peripheral neuropathy.
BiotechHealthtechMedical DevicesSan Diego, US
Stan Kim(Executive Officer, Director)inNigel Calcutt(Director)
Co-investorsThynk Capital
X-Therma develops a proprietary peptoid-based technology that inhibits ice crystal formation to enable long-term sub-zero preservation and transport of cells, tissues, organs, and other biologics.
BiotechDeep TechMedical DevicesNew MaterialsRichmond, US
Xiaoxi Wei(Founder & CEO)inMark Kline(Executive Officer, Director)inJohannes Weggemann(Director)
Co-investorsAurum Venture PartnersDellin InvestmentsLIFTTMethuselah FoundationPortfoliaVU Venture Partners+1 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Turn
Exits · 1
1 acquisitionsVolumetricacq. by 3D Systems
Frequently asked questions
- How many investments has Methuselah Funds made?
- Methuselah Funds has 8 tracked investments, 1 of which have exited.
- Where is Methuselah Funds located?
- Methuselah Funds is headquartered in Springfield, US.
- Who does Methuselah Funds co-invest with?
- Methuselah Funds most often shares deals with Methuselah Foundation, Harmonix Fund, Helios Capital, among 18 tracked co-investors.